DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
KEY PRODUCTS
Reset all filters
01 1Dr. Reddy's Laboratories
Reset all filters
01 1ATORVASTATIN CALCIUM (BUTYLATED HYDROXY ANISOLE PREMIX)
Reset all filters
01 1India
Reset all filters
01 1Active
Reset all filters
01 1Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25902
Submission : 2012-03-23
Status : Active
Type : II
20
Dr Reddys Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is ATORVASTATIN CALCIUM (BUTYLATED HYDROXY ANISOLE PREMIX), with a corresponding US DMF Number 25902.
Remarkably, this DMF maintains an Active status since its submission on March 23, 2012, highlighting commitment to regulatory compliance.